Harrow Stock

Harrow Current Ratio

The Current Ratio of Harrow (HROW) as of Aug 5, 2026 is 1.36. In the previous year, Current Ratio was 1.32 — a change of 3.16% (higher).

Current Ratio

1.36

YoY

3.16%

Last updated:

Current Ratio of Harrow is 2026 1.36 . Current Ratio of Harrow was 2025 1.32 . It decreases by 3.16% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Current Ratio of Harrow is 1.36 in 2026.

Current Ratio of Harrow changed from 1.32 to 1.36, representing a 3.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Harrow since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Harrow

All Key Metrics — Harrow